Science and Research

Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells

SARS-CoV-2 is a single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Given its acute and often self-limiting course, components of the innate immune system are likely central in controlling virus replication thereby determining clinical outcome. Natural killer (NK) cells are innate lymphocytes with notable activity against a broad range of viruses, including RNA viruses(1,2). NK cell function may be altered during COVID-19 despite increased representation of NK cells with an activated and 'adaptive' phenotype(3,4). Here we show that viral load decline in COVID-19 correlates with NK cell status and that NK cells can control SARS-CoV-2 replication by recognizing infected target cells. In severe COVID-19, NK cells show remarkable defects in virus control, cytokine production and cell-mediated cytotoxicity despite high expression of cytotoxic effector molecules. Single-cell RNA-sequencing (scRNA-seq) of NK cells along the time course of the entire COVID-19 disease spectrum reveals a unique gene expression signature. Transcriptional networks of interferon-driven NK cell activation are superimposed by a dominant TGFβ response signature with reduced expression of genes related to cell-cell adhesion, granule exocytosis and cell-mediated cytotoxicity. In severe COVID-19, serum levels of TGFβ peak during the first 2 weeks of infection, and serum obtained from these patients profoundly inhibits NK cell function in a TGFβ-dependent manner. Our data reveal that untimely production of TGFβ is a hallmark of severe COVID-19 and may inhibit NK cell function and early virus control.

  • Witkowski, M.
  • Tizian, C.
  • Ferreira-Gomes, M.
  • Niemeyer, D.
  • Jones, T. C.
  • Heinrich, F.
  • Frischbutter, S.
  • Angermair, S.
  • Hohnstein, T.
  • Mattiola, I.
  • Nawrath, P.
  • Mc Ewen, S.
  • Zocche, S.
  • Viviano, E.
  • Heinz, G. A.
  • Maurer, M.
  • Kölsch, U.
  • Chua, R. L.
  • Aschman, T.
  • Meisel, C.
  • Radke, J.
  • Sawitzki, B.
  • Roehmel, J.
  • Allers, K.
  • Moos, V.
  • Schneider, T.
  • Hanitsch, L.
  • Mall, M. A.
  • Conrad, C.
  • Radbruch, H.
  • Duerr, C. U.
  • Trapani, J. A.
  • Marcenaro, E.
  • Kallinich, T.
  • Corman, V. M.
  • Kurth, F.
  • Sander, L. E.
  • Drosten, C.
  • Treskatsch, S.
  • Durek, P.
  • Kruglov, A.
  • Radbruch, A.
  • Mashreghi, M. F.
  • Diefenbach, A.
Publication details
DOI: 10.1038/s41586-021-04142-6
Journal: Nature
Work Type: Original
Location: Assoziierter Partner
Disease Area: PALI
Partner / Member: BIH
Access-Number: 34695836

DZL Engagements

chevron-down